Speaker illustration

Doctor Malte Kuniss

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a Danish healthcare perspective

Date: 24 May 2024

Journal: EP Europace Journal

Thumbnail

Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation

Date: 17 March 2021

Journal: EP Europace Journal

Thumbnail

Cryoballoon ablation of persistent atrial fibrillation: feasibility and safety of left atrial roof ablation with generation of conduction block in addition to antral pulmonary vein isolation

Date: 14 October 2016

Journal: EP Europace Journal

Thumbnail

ESC 365 is supported by